Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes.
Eleanor M. Perfetto, PhD
Advertisement
Articles by Eleanor M. Perfetto, PhD
Eleanor Perfetto, PhD, explores how most favored nation policy relates to broader drug pricing and cost-effectiveness debates in the US.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
Zanubrutinib Outlasting Acalabrutinib in CLL
3
FITs Offer Lowest Environmental Footprint Among CRC Screening Options
4
Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care
5